Parkinson's Disease Research, Education & Clinical Center (PADRECC), Portland VA Medical Center, Portland, OR, USA Oregon Health & Science University, Portland, OR, USA.
J Parkinsons Dis. 2013;3(4):547-55. doi: 10.3233/JPD-130206.
Research in recent years has suggested a role of vitamin D in the central nervous system. The final converting enzyme and the vitamin D receptor are found throughout the human brain. From animal studies vitamin D appears important in neurodevelopment, up-regulation of neurotrophic factors, stabilization of mitochondrial function, and antioxidation.
To examine the relationship between serum vitamin D and neuropsychiatric function in persons with Parkinson's disease (PD).
This is an add-on study to a longitudinal study following neuropsychiatric function in persons with PD. Baseline neuropsychiatric performance and serum 25-hydroxyvitamin D were examined for 286 participants with PD. Measures of global cognitive function (MMSE, MOCA, Mattis Dementia Scale), verbal memory (Hopkins Verbal Learning Test), fluency (animals, vegetables, and FAS words), visuospatial function (Benton Line Orientation), executive function (Trails Making Test and Digit-Symbol Substitution), PD severity (Hoehn & Yahr and Unified Parkinson's Disease Rating Scale) and depression (Geriatric Depression Scale (GDS)) were administered. Multivariate linear regression assessed the association between vitamin D concentration and neuropsychiatric function, in the entire cohort as well as the non-demented and demented subsets.
Using a multivariate model, higher vitamin D concentrations were associated with better performance on numerous neuropsychiatric tests in the non-demented subset of the cohort. Significant associations were specifically found between vitamin D concentration and verbal fluency and verbal memory (t = 4.31, p < 0.001 and t = 3.04, p = 0.0083). Vitamin D concentrations also correlated with depression scores (t = -3.08, p = 0.0083) in the non-demented subset.
Higher plasma vitamin D is associated with better cognition and better mood in this sample of PD patients without dementia. Determination of causation will require a vitamin D intervention study.
近年来的研究表明,维生素 D 在中枢神经系统中发挥作用。最终的转化酶和维生素 D 受体存在于人类大脑的各个部位。从动物研究来看,维生素 D 似乎对神经发育、神经营养因子的上调、线粒体功能的稳定和抗氧化作用很重要。
检查帕金森病(PD)患者血清维生素 D 与神经精神功能之间的关系。
这是一项对 PD 患者神经精神功能进行纵向研究的附加研究。对 286 名 PD 患者进行了基线神经精神表现和血清 25-羟维生素 D 检查。评估了总体认知功能(MMSE、MOCA、Mattis 痴呆量表)、语言记忆(霍普金斯语言学习测试)、流畅性(动物、蔬菜和 FAS 单词)、视空间功能(本顿线定向)、执行功能(Trails 制作测试和数字符号替代)、PD 严重程度(Hoehn 和 Yahr 和统一帕金森病评定量表)和抑郁(老年抑郁量表(GDS))。多元线性回归评估了整个队列以及非痴呆和痴呆亚组中维生素 D 浓度与神经精神功能之间的关联。
使用多元模型,较高的维生素 D 浓度与非痴呆亚组的多项神经心理测试表现更好相关。在非痴呆亚组中,维生素 D 浓度与言语流畅性和言语记忆之间存在显著关联(t = 4.31,p < 0.001 和 t = 3.04,p = 0.0083)。维生素 D 浓度也与非痴呆亚组的抑郁评分相关(t = -3.08,p = 0.0083)。
在无痴呆的 PD 患者样本中,较高的血浆维生素 D 与更好的认知和更好的情绪相关。因果关系的确立需要进行维生素 D 干预研究。